Catalyst Wire Dossier Catalyst Wire Dossier

Vihuma

simoctocog alfa · Octapharma AB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vihuma, covering 2023-03-21 to 2023-03-21. Get the full timeline:

Most recent: EMA Authorised: Vihuma (simoctocog alfa) — Octapharma AB

See pricing